Comparison of the effects of amantadine and ondansetron in treatment of fatigue in patients with multiple sclerosis.

Mojtaba KhazaeiAshkan KarevanMohammad TaheriSoudeh Ghafouri-Fard

Published in: Clinical and translational medicine (2019)

Both amantadine and ondansetron reduce fatigue in MS patients, but the efficacy of amantadine in reducing the MS-associated fatigue is greater than that of ondansetron.

Keyphrases

mass spectrometry
sleep quality
multiple sclerosis
end stage renal disease
ms ms
ejection fraction
newly diagnosed
chemotherapy induced
prognostic factors
patient reported
combination therapy